DIGITAL EDITION

ARCHIVES

CURRENT ISSUE

Meralgia Paresthetica Successfully Treated with Palmithoylethanolamide

by Rocco Salvatore Calabrò MD, PhD; Carmela Casella, MD; Alfredo Manuli, MSc; David Militi, MD; and Giuseppe Gervasi, MD, PhD Drs. Calabrò and Manuli are with IRCCS Centro Neurolesi “Bonino

Behavioral Activation Contributed to the Total Reduction of Depression Symptoms in the Smartphone-based Cognitive Behavioral Therapy: A Secondary Analysis of a Randomized, Controlled Trial

by Hissei Imai, MD, PhD; Mitsuhiko Yamada, MD, PhD; Masatoshi Inagaki, MD, PhD; Norio Watanabe, MD, PhD; Bun Chino, MD, PhD; Akio Mantani, MD, PhD; and Toshiaki A Furukawa, MD,

Latency to First Event is Shorter in Psychogenic Non-epileptic Seizures Than in Epileptic Seizures in an Epilepsy Monitoring Unit

by Vishwanath Sagi MBBS, MPH; Jaime Shoup MD; Ravikiran Chilukuri; and M. Steven Evans MD Drs. Sagi and Evans are with the Department of Neurology at the University of Louisville

The Depression Inventory Development Scale: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial

by Anthony L. Vaccarino, PhD; Amir H. Kalali, MD; Pierre Blier, MD, PhD; Susan Gilbert Evans, MSc; Nina Engelhardt, PhD; Jane A. Foster, PhD; Benicio N. Frey, MD, PhD; John

Layperson/Plain Language Summaries: Can Sponsors, CROs, and Sites Deliver in 2020?

by Charles S. Wilcox, PhD, MPA, MBA; Leslie Franceschi, BA; and ADAM SIMMONS, MPH Dr. Wilcox is Chief Executive Officer at Praxis Research Consulting in Newport Beach, California. Ms. Franceschi